Archive for October, 2007|Monthly archive page

The business of genomics: a grabbag of companies on the move

A few more companies that have recently appeared on the radar:
Complete Genomics

“Complete Genomics (CGI) is a high-performance DNA sequencing company whose mission is to dramatically reduce the cost of DNA sequencing for research, drug development, and diagnostic applications.”

On their Science Advisory Board is Mark Chee, Ph.D., the co-founder of Illumina, who is presently Chief Executive Officer and Chief Scientific Officer of Prognosys Biosciences.

Prognosys Bio homepage says the following about their business plans…

“Prognosys Biosciences is developing innovative assay technologies. Our strategy is twofold: to make them available for applications ranging from basic research to clinical diagnostics; and to use them to discover and validate molecular markers that have prognostic value.”

High Throughput Genomics, Inc. says they add speed and accuracy to drug discovery.

These companies join the ranks of Helicos, ABI, Illumina, and 454, all of whom can produce entire genome sequences with ultra-high-throughput sequencing systems.

Advertisements